Weekly Recap

NeurologyLive Weekly Recap

Each week on Saturday morning, the NeurologyLive^® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

Fingolimod Preserves MS Cognition, Ravulizumab ALS Trial Discontinued, ADVANCE Results Published

NeurologyLive® Staff

August 28th 2021

Neurology News Network for the week ending August 28, 2021.

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

ACTH Superior to Treat Infantile Spasms, SESI-HRMS Serves as Viable OSA Screening Tool, Myeloid Microvesicles Diagnostic Value in MS

NeurologyLive® Staff

August 21st 2021

Neurology News Network for the week ending August 21, 2021.

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

DTAS Leads to Improved Stroke Outcomes, FDA Approves Avalglucosidase Alfa, No Evidence of Suicidality in ASMs

NeurologyLive® Staff

August 14th 2021

Neurology News Network for the week ending August 14, 2021.

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

Seizure Detection Using Machine Learning, Seroconversion Rate Lower in Anti-CD20 Therapies, Age of Diabetes Onset Correlated With Dementia

NeurologyLive® Staff

August 7th 2021

Neurology News Network for the week ending August 7, 2021.

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

Cenobamate Shows High Retention, Increased Risk of Depression in MS, DAPT Therapy Benefits Moderate Ischemic Stroke

NeurologyLive® Staff

Neurology News Network for the week ending July 24, 2021.

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

Starstim Device Granted Breakthrough Designation, Natalizumab Reduces Postpartum Relapse Risk, EFRONT Dementia Study Announced

NeurologyLive® Staff

Neurology News Network for the week ending July 17, 2021.

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

Narcolepsy Severity Scale Shows Benefit, Amantadine Improves Daily Living, Pridopidine's Neuroprotective Properties

NeurologyLive® Staff

Neurology News Network for the week ending July 10, 2021.

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

Lemborexant Shows Positive Medication Effect, New Comparative Study for CGRPs Announced, Ultra-Early Epilepsy Surgery Effective

NeurologyLive® Staff

Neurology News Network for the week ending July 2, 2021.

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

Eptinezumab Demonstrates Rapid Relief, Zolgensma Improves Motor Function in SMA, RELIEF Study Results

NeurologyLive® Staff

Neurology News Network for the week ending June 26, 2021.

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

Blarcamesine Exceeds Enrollment, Higher Plasma Nusinersen Leads to Meaningful Improvements, Neurodevelopmental Outcomes Unchanged by Maternal ASMs

NeurologyLive® Staff

Neurology News Network for the week ending June 19, 2021.

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

Telemedicine Produces Meaningful Migraine Improvement, Galcanezumab Shows No Wearing Effect, CGRPs All Significant Improve MMDs

NeurologyLive® Staff

Neurology News Network for the week ending June 12, 2021.

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

Experts Call for Better Trial Design, Alzheimer Disease Vaccine Shows Safety, FDA Accepts IND for LION-101

NeurologyLive® Staff

Neurology News Network for the week ending June 5, 2021.

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

ANVS401 Shows Promise in Alzheimer Disease, FDA Approves IND for Ketamine in Parkinson, MedRhythms Collaborates With Massachusetts General Hospital

NeurologyLive® Staff

Neurology News Network for the week ending May 29, 2021.

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

ET Associated With Substantial HCRU, MS Phenotypes Share Common Mechanisms, Hypertension Risk in Menopausal Women With Migraine

NeurologyLive® Staff

Neurology News Network for the week ending May 22, 2021.

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

Gene Therapy in SLC13A5 Deficiency, DMTs Reduce Risk of Disability in Pediatric MS, FASTEST Phase 3 Study Announced

NeurologyLive® Staff

Neurology News Network for the week ending May 15, 2021.

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

VY-HTT01 IND Accepted, SUDEP Associated With Abnormal Cardiac Response, Humoral Response in MS DMTs Identified

NeurologyLive® Staff

Neurology News Network for the week ending May 8, 2021.

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

Tofersen to Begin Expanded Access, FDA Grants De Novo to Chronic Stroke Rehab Therapy, Brain MRI to Predict Post-Partum Relapses

NeurologyLive® Staff

Neurology News Network for the week ending May 1, 2021.

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

Stroke Common Cause of Seizures, Inebilizumab Demonstrates Continued Benefits, Fremanezumab Safe in Patients With CV Risk

NeurologyLive® Staff

April 24th 2021

Neurology News Network for the week ending April 24, 2021.

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

Risdiplam Demonstrates Continued Improvements in SMA, Cortical Hyperexcitability in ALS, Retinal Atrophy Modulated With Rituximab

NeurologyLive® Staff

April 17th 2021

Neurology News Network for the week ending April 17, 2021.

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

RESILIENT Long-Term Extension Data, Associations Between Abuse and Migraine, Retinal Biomarkers in Alzheimer Disease

NeurologyLive® Staff

April 10th 2021

Neurology News Network for the week ending April 10, 2021.

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

HD Treatment Tominsersen Discontinued, FDA Approves Atogepant NDA, NurOwn's Promising Results in Progressive MS

NeurologyLive® Staff

Neurology News Network for the week ending April 3, 2021.

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

Racial Disparities in EVT Access, Forced Exercise Impact on Poststroke Patients, EVT Benefits Within 24 Hour Window

NeurologyLive® Staff

March 27th 2021

Neurology News Network for the week ending March 27, 2021.

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

Risdiplam in Symptomatic SMA, Nusinersen Preserves Swallowing, Ataluren Delays Ambulation in DMD

NeurologyLive® Staff

March 20th 2021

Neurology News Network for the week ending March 20, 2021.

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

FDA Approves NeuroCap EEG Device, Surgical Approaches Advantages Identified, Ocrelizumab Observed in Elders

NeurologyLive® Staff

March 13th 2021

Neurology News Network for the week ending March 13, 2021.

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

Electronic Pill Bottle Improves DMT Adherence, Subcutaneous Cladribine Personalized Dosing Well-Tolerated, MS Fatigue Unchanged Long-Term

NeurologyLive® Staff

Neurology News Network for the week ending March 6, 2021.

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

Siponimod Improves Cognitive Processing Speed, Opioid Use for Migraine in Emergency Departments, Reduced Stroke Admissions During Pandemic

NeurologyLive® Staff

February 27th 2021

Neurology News Network for the week ending February 27, 2021.

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

JZP-258 sNDA Accepted, FDA Clears gammaCore nVNS, Prevalence of Seizure Cycles

NeurologyLive® Staff

February 20th 2021

Neurology News Network for the week ending February 20, 2021.

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

FDA Approves Genio OSA Therapy, Improved Motor Function With FUS, Soticlestat Evaluated in Dravet Sydrome

NeurologyLive® Staff

February 13th 2021

Neurology News Network for the week ending February 13, 2021.

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

Rituximab Suppresses Inflammatory Disease in MS, IND Filed for ImmCelz, Laser Ablation Safe in Focal Epilepsy

NeurologyLive® Staff

February 6th 2021

Neurology News Network for the week ending February 6, 2021.

FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS

FDA Grants BREN-02 Orphan Drug Designation, Memory Preservation in Primary Progressive Aphasia, Phenotypes of MS

NeurologyLive® Staff

January 30th 2021

Neurology News Network for the week ending January 30, 2021.

...

3 4 5 6 7 8 9 10 >

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.